Search for: "Wyeth Pharmaceuticals, Inc. " Results 161 - 180 of 517
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
3 Apr 2007, 6:20 am
(noting that "Switzerland's Serono and Germany's Schering, Altana and Schwarz were all sold in 2006" and that "Britain's Astra Zeneca and America's Wyeth and Bristol-Myers Squibb" may be the next targets for larger, acquiring firms) [read post]
20 Sep 2011, 6:35 am by Bexis
Wyeth, Inc., ___ F.3d ___, 2011 WL 4389211, slip op. (6th Cir. [read post]
2 Aug 2012, 10:17 am by FDABlog HPM
Liggett Group, Inc., 505 U.S. 504 (1992)—that federal law does not preempt state law design-defect claims targeting generic pharmaceutical products because the conceded conflict between such claims and the federal laws governing generic pharmaceutical design allegedly can be avoided if the makers of generic pharmaceuticals simply stop making their products. [read post]
22 Jun 2010, 6:56 am
On Scroggin's behalf, personal injury product liability attorneys sued drug makers Wyeth Pharmaceuticals and Upjohn Co., both now subsidiaries of Pfzier Inc., claiming that hormone replacement drugs they manufactured were responsible for Scroggin's breast cancer. [read post]
28 Jun 2016, 9:02 am by Dean Freeman
Wyeth Inc., in ruling in 2008 that the maker of a drug called Reglan could be liable to a plaintiff who used the generic version.The state supreme court declined to hear the Conte case, so this will be the first time that court will consider a challenge like this. [read post]
3 Jun 2009, 5:49 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Singulair (Montelukast) – US: Merck & Co’s Singulair patent challenged on $50K bounty (Patent Baristas) (GenericsWeb)   General Docs at BIO (Panel addresses narrowing scope of biotech patents – Patent Docs), (‘Perfect storm’ super session – Patent Docs) (Biotech… [read post]
3 Jun 2009, 5:49 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Singulair (Montelukast) – US: Merck & Co’s Singulair patent challenged on $50K bounty (Patent Baristas) (GenericsWeb)   General Docs at BIO (Panel addresses narrowing scope of biotech patents – Patent Docs), (‘Perfect storm’ super session – Patent Docs) (Biotech… [read post]
29 Mar 2007, 4:46 am
Wyeth Labs., Inc., 161 N.J. 1, 25 (1999). [read post]